Clinical Trials Directory

Trials / Sponsors / Armando Santoro, MD

Armando Santoro, MD

Academic / Other · 18 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingNiraparib and Temozolomide in Patients Glioblastoma
Glioma, Malignant
Phase 1 / Phase 22024-09-01
TerminatedAnti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve
Breast Cancer
Phase 22013-05-01
CompletedStudy of Tivantinib (ARQ 197) Plus Cetuximab in EGFR Inhibitor-Resistant MET High Subjects
Colorectal Cancer Metastatic, C-met Overexpression
Phase 22013-03-01
CompletedStudy of the Combination of Tivantinib Plus Pemetrexed and Carboplatin
Malignant Pleural Mesothelioma, Nonsquamous Nonsmall Cell Neoplasm of Lung
Phase 1 / Phase 22013-01-01
CompletedPharmacogenetics Of Vinorelbine In Malignant Pleural Mesothelioma Patients
Malignant Pleural Mesothelioma
—2012-11-01
UnknownStudy of Combination of PIGEV Before Autologous Stem Cell Transplant in Patients With Hodgkin's Lymphoma
Hodgkin's Lymphoma
Phase 12011-07-01
UnknownBendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lympho
Hodgkin's Lymphoma
Phase 22011-07-01
CompletedObservational Prospective Analysis of Biological Characteristics of Mesothelioma Patients
Malignant Mesothelioma
—2011-04-01
CompletedStudy of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy
Thymoma and Thymic Carcinoma
Phase 22011-02-01
UnknownEvaluation of Immunological Reconstitution After Haploidentical Bone Marrow Transplantation
Lymphoma
—2011-01-01
CompletedPemetrexed in Advanced Non-small Cell Lung Cancer
Non-small Cell Lung Cancer (NSCLC)
—2010-09-01
TerminatedStudy of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC
Small Cell Lung Cancer
Phase 1 / Phase 22009-01-01
TerminatedMono Versus Polichemotherapy in Non Small Cell Lung Cancer (NSCLC) Elderly Patients
NSCLC
Phase 22008-10-01
CompletedIdentification of EGFR-TKIs Sensitivity or Resistance Markers in NSCLC May Help in Optimal Patient Selection
NON-SMALL-CELL LUNG CANCER
—2008-09-01
TerminatedTrastuzumab Therapy in Non-Small Cell Lung Cancer Patients
NON-SMALL CELL LUNG CANCER
Phase 22008-07-01
CompletedRetrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer
—2007-11-01
CompletedPhase II Study of Bevacizumab, Pemetrexed and Carboplatin as First-Line Therapy in Malignant Pleural Mesotheli
Mesothelioma
Phase 22007-09-01
CompletedPegfilgrastim Versus Filgrastim After High-dose Chemotherapy
Hematological Neoplasms, Tumors
Phase 22006-09-01